Toth Financial Advisory Corp cut its position in shares of Colgate-Palmolive (NYSE:CL) by 0.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 62,649 shares of the company’s stock after selling 600 shares during the quarter. Toth Financial Advisory Corp’s holdings in Colgate-Palmolive were worth $4,294,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Raymond James Trust N.A. increased its holdings in shares of Colgate-Palmolive by 5.6% in the 1st quarter. Raymond James Trust N.A. now owns 25,554 shares of the company’s stock worth $1,752,000 after buying an additional 1,348 shares during the last quarter. WP Advisors LLC bought a new position in shares of Colgate-Palmolive in the 1st quarter worth $34,000. Ridgewood Investments LLC bought a new position in shares of Colgate-Palmolive in the 1st quarter worth $386,000. Retirement Systems of Alabama increased its holdings in shares of Colgate-Palmolive by 0.3% in the 1st quarter. Retirement Systems of Alabama now owns 401,234 shares of the company’s stock worth $27,501,000 after buying an additional 1,068 shares during the last quarter. Finally, Weybosset Research & Management LLC increased its holdings in shares of Colgate-Palmolive by 0.5% in the 1st quarter. Weybosset Research & Management LLC now owns 68,044 shares of the company’s stock worth $4,664,000 after buying an additional 341 shares during the last quarter. Institutional investors and hedge funds own 75.99% of the company’s stock.
Shares of Colgate-Palmolive stock opened at $70.51 on Wednesday. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.07 and a quick ratio of 0.74. The stock has a market capitalization of $61.77 billion, a P/E ratio of 23.74, a price-to-earnings-growth ratio of 4.72 and a beta of 0.81. Colgate-Palmolive has a 1 year low of $57.41 and a 1 year high of $72.85.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a dividend of $0.43 per share. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a yield of 2.44%. The ex-dividend date of this dividend is Wednesday, April 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.91%.
In related news, VP Justin Skala sold 4,488 shares of the firm’s stock in a transaction that occurred on Tuesday, February 19th. The shares were sold at an average price of $66.39, for a total value of $297,958.32. Following the transaction, the vice president now owns 71,010 shares of the company’s stock, valued at $4,714,353.90. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Noel R. Wallace sold 84,351 shares of the firm’s stock in a transaction that occurred on Wednesday, May 1st. The stock was sold at an average price of $71.89, for a total transaction of $6,063,993.39. Following the completion of the transaction, the chief executive officer now directly owns 279,023 shares in the company, valued at approximately $20,058,963.47. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 246,149 shares of company stock valued at $17,203,908. 1.14% of the stock is owned by company insiders.
A number of equities research analysts have recently issued reports on CL shares. Goldman Sachs Group raised shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research note on Tuesday, January 8th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $61.00 price objective on shares of Colgate-Palmolive in a research note on Friday, February 1st. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 30th. BNP Paribas raised shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and increased their price target for the company from $56.00 to $67.00 in a research report on Monday, February 11th. Finally, Evercore ISI initiated coverage on shares of Colgate-Palmolive in a research report on Thursday, January 10th. They set an “outperform” rating and a $70.00 price target for the company. One investment analyst has rated the stock with a sell rating, thirteen have given a hold rating and five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $69.69.
COPYRIGHT VIOLATION NOTICE: “Colgate-Palmolive (NYSE:CL) Shares Sold by Toth Financial Advisory Corp” was posted by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/05/08/toth-financial-advisory-corp-has-4-29-million-stake-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Recommended Story: What is the balance sheet?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.